These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20203148)

  • 21. Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS.
    Tur C; Khaleeli Z; Ciccarelli O; Altmann DR; Cercignani M; Miller DH; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):423-8. PubMed ID: 20974648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP; Rovaris M; Comi G; Filippi M
    Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a.
    Dubois B; Leary SM; Nelissen I; Opdenakker G; Giovannoni G; Thompson AJ
    J Neurol; 2003 Sep; 250(9):1037-43. PubMed ID: 14504963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between structural CNS damage and functional MRI changes in primary progressive MS.
    Filippi M; Rocca MA; Falini A; Caputo D; Ghezzi A; Colombo B; Scotti G; Comi G
    Neuroimage; 2002 Mar; 15(3):537-46. PubMed ID: 11848696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
    Penny S; Khaleeli Z; Cipolotti L; Thompson A; Ron M
    Neurology; 2010 Feb; 74(7):545-52. PubMed ID: 20157157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demyelination versus remyelination in progressive multiple sclerosis.
    Bramow S; Frischer JM; Lassmann H; Koch-Henriksen N; Lucchinetti CF; Sørensen PS; Laursen H
    Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
    Bosma LV; Kragt JJ; Brieva L; Khaleeli Z; Montalban X; Polman CH; Thompson AJ; Tintoré M; Uitdehaag BM
    Mult Scler; 2010 Jul; 16(7):862-7. PubMed ID: 20488826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical scales in progressive MS: predicting long-term disability.
    Bosma LV; Kragt JJ; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Mar; 18(3):345-50. PubMed ID: 21868487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of MRI of the brain and spinal cord, and CSF examination for the diagnosis of primary progressive multiple sclerosis.
    Nilsson P; Sandberg-Wollheim M; Norrving B; Larsson EM
    Eur J Neurol; 2007 Nov; 14(11):1292-5. PubMed ID: 17764461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.
    Khaleeli Z; Sastre-Garriga J; Ciccarelli O; Miller DH; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1076-82. PubMed ID: 17287235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
    Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
    Kelly SB; Kinsella K; Duggan M; Tubridy N; McGuigan C; Hutchinson M
    Mult Scler; 2013 Jul; 19(8):1095-100. PubMed ID: 23132903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
    van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
    Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data.
    Sastre-Garriga J; Ingle GT; Rovaris M; Téllez N; Jasperse B; Altmann DR; Benedetti B; Stevenson VL; Cercignani M; Leary SM; Barkhof F; Brochet B; Dousset V; Filippi M; Montalban X; Kalkers NF; Polman CH; Rovira A; Miller DH; Thompson AJ
    Neurology; 2005 Aug; 65(4):633-5. PubMed ID: 16116134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study.
    Khaleeli Z; Ciccarelli O; Manfredonia F; Barkhof F; Brochet B; Cercignani M; Dousset V; Filippi M; Montalban X; Polman C; Rovaris M; Rovira A; Sastre-Garriga J; Vellinga M; Miller D; Thompson A
    Ann Neurol; 2008 Jun; 63(6):790-3. PubMed ID: 18383506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time.
    Jacobi C; Hähnel S; Martinez-Torres F; Rieger S; Jüttler E; Heiland S; Jarius S; Meyding-Lamadè U; Storch-Hagenlocher B; Wildemann B
    Eur J Neurol; 2008 Dec; 15(12):1359-64. PubMed ID: 19049554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.
    Bodini B; Battaglini M; De Stefano N; Khaleeli Z; Barkhof F; Chard D; Filippi M; Montalban X; Polman C; Rovaris M; Rovira A; Samson R; Miller D; Thompson A; Ciccarelli O
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):72-7. PubMed ID: 20627965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.